CoreWeave (CRWV) Form 144: Insider 10b5-1 Sales Total ~$17.6M

Rhea-AI Filing Summary

Form 144 notice for CoreWeave, Inc. (CRWV) reports a proposed sale of 32,455 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $4,248,034.95 and approximately 370,470,348 shares outstanding. The filing lists the shares as acquired 02/23/2020 in connection with Series A preferred stock conversion or transaction and shows the approximate sale date as 09/24/2025 on NASDAQ. The filing also discloses multiple recent 10b5-1 sales during August and September 2025 by Michael Intrator and Omnadora Capital LLC, totaling four transactions listed with gross proceeds of $3,840,276.82, $5,916,310.00, $3,104,307.77, and $4,782,480.00 respectively. The notice includes the standard certification that the seller is not aware of undisclosed material adverse information.

Positive

• Transparent disclosure of proposed sale details including broker, share count, market value, and exchange
• Use of 10b5-1 plans for recent sales indicates pre-established trading arrangements and procedural compliance

Negative

• Significant insider/officer liquidity: four recent 10b5-1 sales with combined gross proceeds of approximately $17,643,374.59
• Sale size relative to outstanding shares: the proposed 32,455-share sale represents a non-zero insider exit against 370,470,348 shares outstanding

Insights

Securities Analyst

TL;DR: Routine Rule 144 sale and multiple 10b5-1 transactions disclose significant insider/officer-related liquidity but no new operational information.

The filing documents a planned 32,455-share sale valued at $4.25M and four recent 10b5-1 sales by named sellers with combined gross proceeds of roughly $17.64M. These entries are execution and disclosure events rather than operational or financial performance signals. For investors, the items are material as insider liquidity events but do not, by themselves, provide information about company operations, results, or governance changes.

Corporate Governance Expert

TL;DR: Disclosure is consistent with compliance; multiple 10b5-1 sales suggest pre-approved trading plans and transparency in insider selling.

The form identifies broker details, acquisition history (02/23/2020, Series A preferred stock), and 10b5-1 sales by Michael Intrator and Omnadora Capital LLC. The presence of 10b5-1 transactions indicates trading under pre-established plans, reducing the likelihood of opportunistic trading, but the filings should be monitored for timing relative to material announcements. No governance changes or undisclosed material facts are stated in this document.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32455	4248034.95	370470348	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2020	Series A preferred stock	Issuer			32455	02/23/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	32455	3840276.82
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/10/2025	50000	5916310.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	32455	3104307.77
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	50000	4782480.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRWV Form 144 report?

The form reports a proposed sale of 32,455 common shares via Morgan Stanley Smith Barney valued at $4,248,034.95, with an approximate sale date of 09/24/2025 on NASDAQ.

Who carried out recent 10b5-1 sales disclosed in this filing?

The filing lists 10b5-1 sales by Michael Intrator and Omnadora Capital LLC, executed on 08/27/2025 and 09/10/2025.

How much were the gross proceeds from recent sales?

The four listed recent transactions show gross proceeds of $3,840,276.82, $5,916,310.00, $3,104,307.77, and $4,782,480.00.

When and how were the securities being sold originally acquired?

The securities to be sold were acquired on 02/23/2020 in connection with Series A preferred stock, with the amount listed as 32,455 shares.

Does the filing state there is undisclosed material information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.